Indeed, higher levels of circulating IL-6 have been detected in CAPS patients compared to healthy controls, and IL-1 blockade in CAPS has been reported to reduce serum levels of IL-6 (16). This evidence concerns the gene IL6 and cryopyrin-associated periodic syndrome.